These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1970766)

  • 1. Pharmacokinetics and metabolism of the pharmacologically active 4'-hydroxylated metabolite of propranolol in the dog.
    Christ DD; Walle UK; Oatis JE; Walle T
    Drug Metab Dispos; 1990; 18(1):1-4. PubMed ID: 1970766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective sulfation of R,S-4'-hydroxypropranolol by canine hepatic cytosol and partially purified phenolsulfotransferases.
    Christ DD; Walle T
    J Pharmacol Exp Ther; 1989 Dec; 251(3):949-55. PubMed ID: 2600823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and metabolism of oral doses of a 4'-methylthio derivative of propranolol in man.
    Walle T; Walle UK; Cowart TD; Conradi EC; Gaffney TE
    Xenobiotica; 1990 Mar; 20(3):321-31. PubMed ID: 2336841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and metabolism of a 4'-methylthio derivative of propranolol in the dog.
    Bai SA; Easterling DE; Wilson MJ; Walle UK; Haney CA; Peet NP; Pruett JK; Walle T
    Drug Metab Dispos; 1989; 17(5):495-505. PubMed ID: 2573492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing.
    Lankford SM; Maskasame C; Bai SA
    Drug Metab Dispos; 1994; 22(5):776-87. PubMed ID: 7835231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereochemical composition of propranolol metabolites in the dog using stable isotope-labeled pseudoracemates.
    Walle T; Wilson MJ; Walle UK; Bai SA
    Drug Metab Dispos; 1983; 11(6):544-9. PubMed ID: 6140137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of major sulfate conjugates in the metabolism of propranolol in dog and man.
    Walle T; Walle UK; Knapp DR; Conradi EC; Bargar EM
    Drug Metab Dispos; 1983; 11(4):344-9. PubMed ID: 6137341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective oral bioavailability of (+/-)-propranolol in the dog. A GC-MS study using a stable isotope technique.
    Walle T; Walle UK
    Res Commun Chem Pathol Pharmacol; 1979 Mar; 23(3):453-64. PubMed ID: 461970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative metabolic fate of propranolol in the dog, rat, and hamster using radiotracer, high performance liquid chromatography, and gas chromatography-mass spectrometry techniques.
    Bargar EM; Walle UK; Bai SA; Walle T
    Drug Metab Dispos; 1983; 11(3):266-72. PubMed ID: 6135586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New ring-hydroxylated metabolites of propranolol: species differences and stereospecific 7-hydroxylation.
    Walle T; Oatis JE; Walle UK; Knapp DR
    Drug Metab Dispos; 1982; 10(2):122-7. PubMed ID: 6124396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition.
    Marathe PH; Shen DD; Nelson WL
    Drug Metab Dispos; 1994; 22(2):237-47. PubMed ID: 8013280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective increase in propranolol bioavailability during chronic dosing in the dog.
    Bai SA; Wilson MJ; Walle UK; Walle T
    J Pharmacol Exp Ther; 1983 Nov; 227(2):360-4. PubMed ID: 6631718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective sulfate conjugation of racemic 4-hydroxypropranolol by human and rat liver cytosol.
    Walle T; Walle UK
    Drug Metab Dispos; 1991; 19(2):448-53. PubMed ID: 1676652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereoselective differences in propranolol disposition in female Sprague-Dawley and Dark Agouti rats.
    Guttendorf RJ; Kostenbauder HB; Wedlund PJ
    Drug Metab Dispos; 1991; 19(1):251-6. PubMed ID: 1673410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of effect of spinal anesthesia on drug metabolism.
    Whelan E; Wood AJ; Shay S; Wood M
    Anesth Analg; 1989 Sep; 69(3):307-12. PubMed ID: 2774225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicokinetics of a single intravenous dose of rac-propranolol versus optically pure propranolol in the rat.
    Bode W; Toet AE; Stolker AA; van Ginkel LA; Groen K; Wemer J; de Wildt DJ
    Chirality; 1995; 7(8):626-31. PubMed ID: 8593256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
    Vu VT; Bai SA; Abramson FP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):55-61. PubMed ID: 6848749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidation of (R)- and (S)-propranolol in human and dog liver microsomes. Species differences in stereoselectivity.
    von Bahr C; Hermansson J; Lind M
    J Pharmacol Exp Ther; 1982 Aug; 222(2):458-62. PubMed ID: 7097564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselective disposition of propranolol in rabbits. Role of presystemic organs and dose.
    Marier JF; Pichette V; du Souich P
    Drug Metab Dispos; 1998 Feb; 26(2):164-9. PubMed ID: 9456303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-dealkylation of propranolol in rat, dog, and man. Chemical and stereochemical aspects.
    Nelson WL; Bartels MJ
    Drug Metab Dispos; 1984; 12(3):345-52. PubMed ID: 6145562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.